Phase 1 PK/PD Study of ASN003, a novel highly selective BRAF and PI3K inhibitor, in patients with advanced solid tumorsD. Rasco,R. Sullivan,N. Lakhani,S. Reddy,N. Rao,L. Denis,A. Tolcher,K. T. FlahertyAnnals of Oncology(2017)引用 0|浏览11暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要